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Abstract
Objective: The 2- and 6-minute walk tests are common measures for evaluating walking ability, but reliability is
weakened by a well-documented learning effect. Since heart rate is related to workload, any change in walking
distance, which is unrelated to change in clinical function, should be reflected in a change in heart rate during
walking. Therefore, the aim of the present study was to investigate test-retest reliability of the 2- and 6-minute walk
tests with and without heart rate correction.
Methods: Ninety-three adult patients (mean age of 53 years, range; 22-83 years) with 12 different neuromuscular
diseases (myotonic dystrophy type 1, limb-girdle muscular dystrophy, facioscapulohumeral muscular dystrophy type
1, Charcot-Marie-Tooth disease, mitochondrial myopathy, Becker muscular dystrophy, spinobulbar muscular atrophy,
sporadic inclusion body myositis, spinal muscular atrophy, myotonia congenita Thomsen disease, congenital
myopathy, polymyositis) were recruited in the study. One 2- and 6-minute walk test was performed on two
occasions, 1-2 weeks apart. Heart rate was monitored by a pulse-watch.
Results: The distance walked increased significantly with repeated 2- and 6-minute walk tests (2-minute walk
test increased by 4 ± 9 m and 6-minute walk test by 11 ± 26 m, p<0.001). Heart rate correction eliminated the
learning effect in the 6-minute walk test (+0.01 m/heartbeat, p=0.84), but not in the 2-minute walk test (+0.03 m/
heartbeat, p=0.018). The same pattern of heart rate-correction in the 6-minute walk test was observed in all
subgroup diagnoses. There was no difference in the learning effect between disease severities.
Conclusion: Both the 2- and 6-minute walk tests are associated with a learning effect. The learning effect is
eliminated when correcting for heart rate in the 6-minute walk test, but not in the 2-minute walk test. The results
suggest using a heart rate corrected 6-minute walk test to weed out day-to-day variations that are not due to a real
change in the patient’s clinical condition.
Keywords: Walk test; Neuromuscular diseases; Reproducibility of
results; Psychometrics
Introduction
The 2-minute walk test (2MWT) and 6-minute walk test (6MWT)
are submaximal exercise tests that are easy to administer and require
no expensive equipment [1]. Both tests are used in the clinic and in
clinical trials for evaluating walking ability in patients with
neuromuscular diseases (NMDs). The 6MWT is by many considered
the gold standard to assess walking capability. However, variability due
to a learning effect, motivation, fatigue and other day-to-day variations
is well documented in the literature in patients with NMDs and non-
NMDs in the 6MWT [1-4] and in non-NMDs in the 2MWT [5-9]. A
learning effect is a better performance at retest, which is not due to
improvement of the clinical condition, but instead a result of
familiarization. A pilot study in 16 patients with neuromuscular
diseases indicated that the variability of the 6MWT can be eliminated
by correcting for heart rate (HR) during the test [2]. The rationale for
eliminating variation in walking distance in the walk tests that is not
due to a real change in the patient’s clinical condition, by HR-
correction is that HR is directly related to the level of physical exertion
[10]. So, any change in walking distance, which is not related to
changes in the physical condition of the test subject, should be
paralleled by changes in HR as an indicator of the level of physical
effort.
This study investigated test-retest reliability of the 2- and 6MWTs
with and without HR-correction in patients with NMDs.
Methods
Subjects
Ninety-three adult patients (mean age of 53 years, range; 22-83
years) with neuromuscular diseases were recruited from Copenhagen
Neuromuscular Center, Rigshospitalet. Inclusion criteria were biopsy
or genetically confirmed neuromuscular disease, age ≥ 18 years and
ability to walk more than 60 meters in the 6MWT to avoid large
variations in performance related to near loss of ambulation. Exclusion
criteria were heart arrhythmias, use of drugs affecting heart rate and
other medical conditions, which could significantly impact on walking
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ability, such as arthritis, generalized pain and some diseases in the
central nervous system.
Procedures
The patients performed one 2MWT and one 6MWT separated by
30 minutes in a block randomized order. The 2- and 6MWTs were
repeated after 1-2 weeks with the same procedure. In the 6MWT, a
patient walks as far as possible in 6 minutes with standard
encouragement by walking back and forth on a 30-meter walk lane
marked by cones. The same applies for the 2MWT. The 6MWT was
performed according to the American Thoracic Society (ATS)
guideline [11], and the 2MWT was comparable to the ATS guideline
regarding equipment and test lane, but the instruction and
encouragement were modified to the shorter duration of the 2MWT.
The patients’ heart rate was monitored during the walking tests with a
Suunto Quest pulse-watch, and the time was recorded for each 30
meters. To avoid confounding factors for interpretation, the patients
were asked to refrain from ingesting caffeine and performing strenuous
exercises from the evening before the test days. Testing was performed
in quiet surroundings and at the same time of the day to minimize
intraday variability. It was the same investigator at test and retest to
avoid inter-rater variability. Data from the walking distance in these
patients has been presented in previous studies [12,13], but Andersen
et al. [12] investigated the validity of the 2MWT compared to the
6MWT, and Knak et al. [13] investigated the absolute- and relative
reliability of the 2- and 6MWTs. In contrast, the present paper targets a
different aspect of reliability by investigating if the variability of 2- and
6MWTs can be eliminated by heart rate correction. At retest, the
patients and investigators were not allowed to check the results from
the first test day to avoid any influence on motivation. To calculate
heart rate correction in the 2- and 6MWTs, the following formula was
used:
Heart rate correction (meter walked/heart beat)=walking distance
(m)/average heart rate
The walking distance was the total distance walked in the walk test.
The average heart rate was of the total duration of the walk test.
The study is approved by the Regional Committee on Health
Research Ethics in Denmark (H-4-2014-FSP). Informed consent was
obtained from all patients.
Statistical analysis
Results are presented as mean ± 2 standard deviations of the mean.
Correlation between walked distance and average HR was assessed by
Pearson product-moment correlation coefficient (r). Reliability was
assessed by a two-sided Student’s paired t-test to check for systematic
differences between tests. Statistical significance was defined by p ≤
0.05. For HR-correction the total walked distance was divided with the
average heart rate during the test.
Results
Characteristics of patients are shown in Table 1 and Figure 1. At the
2MWT retest, 60 patients walked longer, 27 walked shorter, and six
walked the same distance.
 Sex (f/m) Age Height (m) Weight (kg) BMI
MRC MRC
Ankle (d/p) Hip (f/e)
DM1 (15) 4/11 44 ± 15 1.74 ± 0.12 70.5 ± 16.5 23 ± 3.5 4.5 ± 0.6/4.8 ± 0.5 4.9 ± 0.0/4.9 ± 0.2
LGMD (14) 5/9 59 ± 12 1.74 ± 0.09 83.8 ± 15.9 27.5 ± 4.5 4.3 ± 0.9/4.6 ± 0.4 3.7 ± 1.2/3.9 ± 0.9
FSHD1 (11) 6/5 49 ± 18 1.74 ± 0.07 70.4 ± 12.3 23.5 ± 4.5 4.1 ± 1/4.7 ± 0.6 4.3 ± 1.2/4.4 ± 1.0
CMT (12) 5/7 54 ± 16 1.71 ± 0.10 80.5 ± 20.8 27.6 ± 6.2 3.1 ± 1.8/3.7 ± 1.6 4.7 ± 0.3/4.8 ± 0.3
MM (9) 5/4 48 ± 15 1.67 ± 0.14 68.3 ± 18.1 25 ± 8.4 4.8 ± 0.3/4.9 ± 0.2 4.4 ± 1/4.8 ± 0.3
BMD (5) 0/5 35 ± 7 1.79 ± 0.05 87.8 ± 14.6 27.5 ± 5.4 4.6 ± 0.4/4.8 ± 0.4 4.9 ± 0.2/4 ± 0.7
SBMA (13) 0/13 61 ± 10 1.78 ± 0.06 82.3 ± 10.3 25.9 ± 3.1 4.4 ± 0.5/4.4 ± 0.6 4.4 ± 0.5/4.2 ± 0.6
IBM (8) 5/3 76 ± 4 1.68 ± 0.10 63.4 ± 11.4 22.4 ± 2.7 2.9 ± 1.9/3.4 ± 1.6 4 ± 1.4/4.7 ± 0.5
Various (6) 2/4 48 ± 21 1.81 ± 0.10 80.9 ± 8.7 24.8 ± 4 3.3 ± 2.2/4.1 ± 2.0 3.7 ± 1.4/4.7 ± 0.5
All (93) 32/61 53 ± 17 1.74 ± 0.10 76.2 ± 16.3 25.2 ± 5 4 ± 1.6/4.4 ± 1.1 4.4 ± 1/4.5 ± 0.7
Table 1: Patient characteristics. Values are mean ± 2 standard deviations. DM1: Myotonic Dystrophy type 1; LGMD: Limb-Girdle Muscular
Dystrophy; FSHD1: Facioscapulohumeral Muscular Dystrophy type 1; CMT: Charcot-Marie-Tooth disease/Hereditary Motor and Sensory
Neuropathy; MM: Mitochondrial Myopathy; BMD: Becker Muscular Dystrophy; SBMA: Spinobulbar Muscular Atrophy/Kennedy Disease; IBM:
Sporadic Inclusion Body Myositis; Various: Spinal Muscular Atrophy (3), myotonia congenita (Thomsen disease) (1), congenital myopathy (1),
polymyositis (1). Gender: f=female, m=male. BMI: Body Mass Index (BMI: Bodyweight in kg/height in m2). MRC: Medical Research Council
scale (graded as 0, 1, 2, 3, 4, 4.5(4+), and 5), d=dorsal flexion, p=plantar flexion, f=flexion, e=extension. The strength measures are averages of
right and left values in each patient.
Similarly in the 6MWT, 67 patients walked longer at retest, 24
walked shorter, and two walked the same distance.
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Figure 1: Muscle strength in the lower extremities and walking
distance in individual patients. Muscle strength across hip, knee and
ankle measured by Medical Research Council scale (MRC), and
graded as 0, 1, 2, 3, 4, 4.5(4+), and 5. The strength measures are
averages of right and left values in each patient. The walked distance
was the one measured on the first test day. Each dot represents one
patient.
Twenty-eight patients used assistive devices. The total walked
distance in the 2- and 6MWTs correlated with average HR during the
walk tests (r=0.47 and r=0.49 respectively, p<0.001) (Figure 2). The
mean walked distance in the 6MWT increased from the first test day to
the second test day by 11 ± 26 m (2.7%) from 412 to 423 m (p<0.001).
When correcting for HR, the learning effect was abolished (3.79 vs.
3.80 m/heartbeat, p=0.84) (Figure 3). The mean walked distance in the
2MWT increased by 4 ± 9 m (2.9%) from 145 to 149 m (p<0.001). HR-
correction did not abolish the learning effect (1.38 vs. 1.41 m/
heartbeat, p=0.018) (Figure 3). The same pattern of HR-correction in
the 6MWT was observed in all subgroup diagnoses.
There was no difference in the learning effect between disease
severities (difference in walking distance from the first test day to the
second test day in patients who walked <250 m compared to those who
walked >350 m in the first 6MWT: 6MWT p=0.959, 2MWT p=0.759).
Discussion
The present study shows that correcting for average HR during
walking can rectify variations in the 6MWT. This is so, because HR is
directly related to the level of physical exertion [10]. Thus, increments
in walking distance, which are unrelated to clinical improvements, are
paralleled by increases in HR. Similarly, reductions in walking
distance, which are unrelated to clinical deteriorations, are paralleled
by decreases in HR. Thus, the HR-corrected 6MWT is a more
reproducible measure than the standard 6MWT in patients with
NMDs. This finding has important implications for defining a robust
endpoint for clinical follow-up and outcome measure in clinical trials.
It is not surprising that HR-correction did not alter the learning effect
in the 2MWT, as HR during this short test does not reach steady state.
The notion that variations in the 6MWT, which are unrelated to
changes in the patient’s disease status, can be resurrected by correcting
for HR has previously been suggested in neuromuscular diseases [2].
However, this pilot trial [2] was weakened by a small sample of only 16
patients with five different neuromuscular diseases and by only
representing the mildly affected patients. In contrast, the present study
is strengthened by: (i) The large cohort studied (ii) The HR-correction
finding across all disease severities and subgroup diagnoses and (iii)
5-15 patients in most of the NMD groups.
Figure 2: Correlation between walking distance and average heart rate in the 2- and 6MWTs. Data are from the first test day.
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Figure 3: Walking distance for the 2- and 6MWTs. The left column is the walking distance without heart rate correction and the right column
is the walking distance with heart rate correction for the 2- and 6MWTs.
The correlation between average HR and total walking distance
(r=0.49 in the 6MWT and r=0.47 in the 2MWT, p<0.001) was lower
than the significant r=0.73 reported in a pilot trial [2]. Prahm et al. [2]
suggested that the lack of a stronger correlation might be due to non-
compliance of refraining from tobacco and caffeine. However, even
when patients who did not refrain from caffeine, were excluded, the
fair relationship was maintained in the present study (r=0.46 in the 6-
and 2MWTs, p<0.001). Though, self-reporting might be confounded
by social-desirability bias. The difference in the magnitude of the
correlation coefficients between Prahm et al. [2] and the present study
might be due to different samples regarding sample size, specific
neuromuscular diseases, mix of patients and healthy controls and
group heterogeneity.
The present study showed a learning effect in both the 2- and
6MWTs when the tests were repeated after 1-2 weeks. The distance
increased by 4 m in the 2MWT, which is comparable to studies in
participants with non-NMDs [5-9], but a learning effect in the 2MWT
has never been investigated before in patients with NMDs. The
increase of 11 m in the 6MWT from test to retest is a little lower than
the 17-24 m reported in other NMD-studies [4-15]. The difference in
walking variability across studies might be due to different sample
sizes, neuromuscular diseases, disease severity and methods. Although
the walking distance increased significantly, several patients walked
shorter at retest, which is consistent with findings from a study of
Duchenne muscular dystrophy [14,15]. This reflects that variability
among repeated tests is not only caused by a learning effect, but also
unpredictable random effects such as motivation, fatigue, and other
day-to-day variations. This study indicates that both upward and
downward variations in walked distance among 6MWTs can be
corrected by heart rate. The learning effect in the 6MWT can last for
several months [1].
Previous studies have recommended to use the best of 2-3 6MWTs
to eliminate the learning effect [1,4]. However, multiple tests are not
always feasible to perform, and are time-consuming and fatiguing for
patients. Therefore, the HR-corrected 6MWT is an alternative to the
standard 6MWT.
HR-corrected 6MWT is useful in patients without cardiac
arrhythmias who do not take drugs affecting the HR. It is primarily
suitable in clinical trials with a drug intervention. It is not suitable if
the intervention is physical training, since increased fitness by itself
changes heart rate responses to exercise. Patients should also refrain
from caffeine intake 12 hours before testing to avoid influence on HR
responses. When comparing two walk tests, retests should optimally be
performed within one year as maximal heart rate decreases by one beat
per minute every year of life after age 25.
The present study was only limited by few protocol violations, such
as not refraining from caffeine or physical exhausting activities close to
the time of testing. However, patients with these minor protocol
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violations showed similar results compared to other patients.
Therefore, the patients were not excluded from the study.
This study shows that a learning effect is also present in the 2MWT
in patients with NMDs, which is known, and also shown in this study,
for the 6MWT. The learning effect is eliminated when correcting for
HR in the 6MWT, but not surprisingly, this was not the case in the
2MWT, and since a steady-state heart rate response is not reached in
this short time. The results suggest using a HR-corrected 6MWT to
weed out day-to-day variations that are not associated with changes in
the patient’s clinical condition.
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